Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Thall

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Statistics in Medicine|March 29, 2001
Optimal two-stage designs for clinical trials based on safety and efficacyP F Thall, S C Cheng
Cancer Treatment and Research|January 1, 1995
Recent developments in the design of phase II clinical trialsP F Thall, R M Simon
Biometrics|April 17, 1998
A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trialsP F Thall, K E Russell
Biometrics|September 1, 1990
Some covariance models for longitudinal count data with overdispersionP F Thall, S C Vail
Statistics in Medicine|August 12, 1998
Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trialsP F Thall, H G Sung
Biometrics|April 21, 2001
Decision theoretic designs for phase II clinical trials with multiple outcomesN Stallard, P F Thall, J Whitehead
Statistics in Medicine|March 15, 1994
New designs for the selection of treatments to be tested in randomized clinical trialsR Simon, P F Thall, S S Ellenberg
Biometrics|September 12, 2001
Dose-finding based on feasibility and toxicity in T-cell infusion trialsP F Thall, H G Sung, A Choudhury
Biometrics|June 1, 1989
Distribution-free confidence intervals for a parameter of Wilcoxon-Mann-Whitney type for ordered categories and progressive censoringM Halperin, M I Hamdy, P F Thall
Biometrics|January 10, 1998
Semiparametric regression analysis for recurrent event interval countsJ G Staniswalis, P F Thall, J Salch
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Statistics in Medicine|March 29, 2001
Optimal two-stage designs for clinical trials based on safety and efficacyP F Thall, S C Cheng
Cancer Treatment and Research|January 1, 1995
Recent developments in the design of phase II clinical trialsP F Thall, R M Simon
Biometrics|April 17, 1998
A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trialsP F Thall, K E Russell
Biometrics|September 1, 1990
Some covariance models for longitudinal count data with overdispersionP F Thall, S C Vail
Statistics in Medicine|August 12, 1998
Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trialsP F Thall, H G Sung
Biometrics|April 21, 2001
Decision theoretic designs for phase II clinical trials with multiple outcomesN Stallard, P F Thall, J Whitehead
Statistics in Medicine|March 15, 1994
New designs for the selection of treatments to be tested in randomized clinical trialsR Simon, P F Thall, S S Ellenberg
Biometrics|September 12, 2001
Dose-finding based on feasibility and toxicity in T-cell infusion trialsP F Thall, H G Sung, A Choudhury
Biometrics|June 1, 1989
Distribution-free confidence intervals for a parameter of Wilcoxon-Mann-Whitney type for ordered categories and progressive censoringM Halperin, M I Hamdy, P F Thall
Biometrics|January 10, 1998
Semiparametric regression analysis for recurrent event interval countsJ G Staniswalis, P F Thall, J Salch
Pageof 6